Générations Santé Numérique (GSN) third-party venue
Serving vulnerable populations in the former Poitou-Charentes region.
Key figures to remember
The Third-Place service offering
Assistance with scoping and project support
- Support for protection and enhancement.
- Customized "onboarding" training module.
- Predictive pathway modeling for definition, evaluation and transfer.
- Software architecture design assistance and user interface prototype.
- Support in obtaining proof of concept.
- Co-design workshops with users.
- Support for the development of experimental projects including assistance in responding to calls for projects: clinical studies, medico-economic studies, usage studies.
- Access to high-level expertise via university research laboratories and partners.
Provision of experimental sites
- Access to a range of platforms and technical platforms for development and experimentation.
Accompaniment in responding to calls for projects and links with our partners for co-support
- Support in the search for transitional funding upstream of target funding (digital advance funding, art. 51, innovation package...).
Composition of the GSN team
The TLE GSN team is made up of:
- a project manager,
- two legal experts,
- three application/network development engineers,
- a data protection delegate,
- and a qualitician/regulatory officer.
Tiers lieu d'expérimentation projects
Project 1: IMASMART
Supplier : Spin-off CHU de Poitiers
Solution: IMASMART, a functional digital solution (TRL 4) that enables early detection of Alzheimer's disease via analysis of everyday smartphone use.
Need: Medical Device classification, Start-up creation and support.
Apport du Tiers-Lieu : Networking/Financing support structures for DM classification, start-up structuring & ISO13485 Quality Management System (QMS)
Project 2: SLEEP SCAN (SOMNO ENGINEERING)
Supplier : Spin-off CHU de Poitiers
Solution: Brain activity recording to monitor the sleep quality of intensive care patients and indicate whether they are in the sleep phase or not, so as not to wake them up with deferrable care. Market launch expected: 2025.
Need : Accompanying Clinical Investigations.
Third-Party Contribution: Help in setting up clinical investigations and medico-economic evaluations in the constitution of the technical file for CE marking.